# A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema

> **NCT01487044** · — · AVAILABLE · sponsor: **Retina Institute of Hawaii**

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Macugen (Pegaptanib Sodium)

## Key facts

- **NCT ID:** NCT01487044
- **Lead sponsor:** Retina Institute of Hawaii
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01487044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01487044, "A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01487044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*